Piribedil

Piribedil is a small molecule drug with a maximum clinical trial phase of IV and is indicated in parkinson disease. It is grouped under the following drug class(es): Dopamine agents and Neurotransmitter agents. Its therapeutic use is listed as antiparkinsonian agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Trivastal and Piribendyl. Its PubChem CID is 4850.

CAS No 3605-01-4
Molecular Formula C16H18N4O2
Molecular Weight 298.34 g/mol
Synonyms 2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine

Frequently Asked Questions